Skip to main content
. 2022 Dec 6;12:1069378. doi: 10.3389/fonc.2022.1069378

Table 2.

IHC analysis of DLBCL cases.

Immunohistochemical Staining In TILs In Tumor cells
The expression in TILs Scoring situation The expression in Tumor cells Scoring situation
(N=174) positive(>0 score) negative(0 score) Low expression(0-3 score) High expression(4-9 score) positive(>0 score) negative(0 score) Low expression(0-3 score) High expression(4-9 score)
PD-1 (138) 79.3% (36) 20.7% (112)64.4% (62) 35.6% (7) 4.0% (167) 96.0%
LAG-3 (137)78.8% (37) 21.2% (108) 62.1% (66)37.9% (5)2.9% (169 )97.1%
TIM-3 (109) 62.7% (65)37.3% (135)77.6% (39) 22.4% (78 )44.8% (96) 55.2% (157) 90.2% (17) 9.8%
TIGIT (121)69.5% (53) 30.5% (107 )61.5% (67)38.5% (79)45.4% (95) 54.6% (161) 92.5% (13) 7.5%

Scoring situation of PD-1 and LAG-3 are not included in the table due to too few positive expression cases in tumor cells.